Dirk Weber
About Dirk Weber
Dirk Weber is the Executive Director of Medical Affairs (Europe) at BeiGene, based in Basel, Switzerland. He has extensive experience in oncology, hemato-oncology, and immuno-oncology, having held various senior roles in the biotech and pharmaceutical industries.
Title and Current Position
Dirk Weber holds the position of Executive Director Medical Affairs (Europe) at BeiGene. He operates out of Basel and the surrounding regions in Switzerland. His role involves leading medical affairs initiatives across Europe, particularly in the oncology domain.
Previous Experience in Biotech and Pharma
Dirk Weber has an extensive background in the biotech and pharmaceutical industries. He has held multiple key positions such as Chief Medical Officer, Medical Advisor, and Clinical Development Expert in various companies. From 2019, he worked in Switzerland's biotech and pharma sectors focusing on drug development in oncology, hemato-oncology, and immuno-oncology. His previous employers include Nexilis AG, TOLREMO therapeutics AG, Elthera AG, Chiltern International / Covance, Cellestia Biotech AG, Takeda Pharmaceuticals, Aurealis Pharma AG, Novartis, Merck Serono, and Ivonex GmbH Kiel.
Education and Medical Training
Dirk Weber completed his medical education at multiple esteemed institutions. He earned his Doctor of Medicine (MD) from Georgetown University School of Medicine. He also studied Humanmedizin at the University of Eastern Finland as an Erasmus student. Furthermore, he studied Oncology and received a Doctor of Medicine (M.D.) from Kiel University. His educational background provided a solid foundation for his multifaceted career in medical affairs and oncology.
Regulatory and Clinical Expertise
Dirk Weber has notable experience in navigating regulatory processes and clinical program management. He played a pivotal role in obtaining regulatory approval for Afinitor in Breast Cancer. He has successfully conducted Health Authority meetings with numerous international regulatory bodies including EMA, FDA, PMDA, cFDA, PEI, MHRA, and FIMEA. His expertise has been crucial in transforming three biotech companies from pre-clinical to clinical development stages and establishing a medical affairs oncology organization in the Emerging Market region.
Core Medical Affairs Activities
With extensive experience in planning and conducting core medical affairs activities, Dirk Weber has contributed significantly to several organizations. His roles have involved strategy development, regulatory negotiations, and clinical oversight. He has continuously contributed to driving forward the medical affairs functions, particularly in oncology, across various regions and organizations.